| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| T1015 |
Clinic visit/encounter, all-inclusive |
95,186 |
72,466 |
$8.85M |
| 99051 |
|
1,972 |
1,566 |
$26K |
| 99050 |
|
459 |
331 |
$5K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
27,109 |
21,814 |
$575.06 |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
46,037 |
36,695 |
$388.46 |
| 3044F |
|
1,048 |
838 |
$380.00 |
| G9919 |
Screening performed and positive and provision of recommendations |
14 |
13 |
$330.00 |
| 3078F |
|
827 |
768 |
$160.00 |
| 3079F |
|
845 |
760 |
$155.00 |
| 3074F |
|
656 |
605 |
$140.00 |
| 0002A |
|
27 |
12 |
$137.14 |
| 3075F |
|
764 |
698 |
$110.00 |
| 3072F |
|
391 |
361 |
$90.00 |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
4,269 |
3,817 |
$71.23 |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
4,908 |
4,389 |
$70.91 |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
5,157 |
4,572 |
$59.59 |
| 3045F |
|
191 |
132 |
$40.00 |
| 92552 |
|
9,527 |
8,487 |
$32.61 |
| 1160F |
|
13,621 |
10,380 |
$30.67 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
7,210 |
6,416 |
$29.51 |
| 0012A |
|
30 |
23 |
$26.20 |
| 99408 |
|
763 |
617 |
$21.22 |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
5,011 |
4,474 |
$18.38 |
| 0011A |
|
55 |
31 |
$15.92 |
| 99173 |
|
10,858 |
9,626 |
$4.10 |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
406 |
306 |
$1.04 |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
1,509 |
1,237 |
$0.94 |
| 96160 |
|
8,505 |
6,888 |
$0.16 |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
4,000 |
3,579 |
$0.06 |
| 96127 |
|
16,488 |
13,594 |
$0.05 |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
1,496 |
1,350 |
$0.03 |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
2,823 |
2,448 |
$0.03 |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
2,852 |
2,520 |
$0.03 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
4,257 |
3,418 |
$0.02 |
| 3725F |
|
11,053 |
9,448 |
$0.02 |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
1,471 |
1,243 |
$0.02 |
| 90474 |
|
695 |
631 |
$0.01 |
| 99406 |
|
272 |
220 |
$0.00 |
| G8510 |
Screening for depression is documented as negative, a follow-up plan is not required |
1,115 |
895 |
$0.00 |
| 90680 |
|
852 |
789 |
$0.00 |
| 90716 |
|
1,166 |
990 |
$0.00 |
| 3061F |
|
1,200 |
943 |
$0.00 |
| 3008F |
|
4,189 |
3,597 |
$0.00 |
| 1111F |
|
1,338 |
1,183 |
$0.00 |
| H0049 |
Alcohol and/or drug screening |
893 |
673 |
$0.00 |
| 90744 |
|
657 |
633 |
$0.00 |
| 00000 |
|
608 |
294 |
$0.00 |
| 90697 |
|
590 |
505 |
$0.00 |
| 90686 |
|
342 |
323 |
$0.00 |
| 90619 |
|
316 |
267 |
$0.00 |
| 99381 |
|
134 |
103 |
$0.00 |
| 90696 |
|
222 |
190 |
$0.00 |
| 99496 |
|
777 |
675 |
$0.00 |
| 90698 |
|
1,258 |
1,184 |
$0.00 |
| 1126F |
|
107 |
82 |
$0.00 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
14 |
13 |
$0.00 |
| G8420 |
Bmi is documented within normal parameters and no follow-up plan is required |
60 |
45 |
$0.00 |
| 90620 |
|
243 |
222 |
$0.00 |
| 90651 |
|
791 |
699 |
$0.00 |
| 3060F |
|
68 |
42 |
$0.00 |
| 85018 |
|
39 |
37 |
$0.00 |
| 1170F |
|
204 |
156 |
$0.00 |
| 90723 |
|
33 |
27 |
$0.00 |
| 2015F |
|
120 |
85 |
$0.00 |
| 2000F |
|
155 |
102 |
$0.00 |
| 90660 |
|
93 |
89 |
$0.00 |
| 91301 |
|
85 |
50 |
$0.00 |
| 90747 |
|
18 |
15 |
$0.00 |
| 2016F |
|
120 |
85 |
$0.00 |
| 82962 |
|
120 |
104 |
$0.00 |
| 87428 |
|
143 |
92 |
$0.00 |
| G0442 |
Annual alcohol misuse screening, 5 to 15 minutes |
16 |
16 |
$0.00 |
| 93000 |
|
13 |
13 |
$0.00 |
| 0001A |
|
74 |
30 |
$0.00 |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
19 |
17 |
$0.00 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
15 |
15 |
$0.00 |
| 1159F |
|
13,602 |
10,380 |
$0.00 |
| 90633 |
|
1,275 |
1,143 |
$0.00 |
| 90670 |
|
1,726 |
1,606 |
$0.00 |
| 81003 |
|
1,074 |
841 |
$0.00 |
| 90707 |
|
1,164 |
989 |
$0.00 |
| 90473 |
|
256 |
228 |
$0.00 |
| 81025 |
|
121 |
91 |
$0.00 |
| 90734 |
|
615 |
552 |
$0.00 |
| 90715 |
|
242 |
221 |
$0.00 |
| 90671 |
|
521 |
423 |
$0.00 |
| G8431 |
Screening for depression is documented as being positive and a follow-up plan is documented |
89 |
71 |
$0.00 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
648 |
509 |
$0.00 |
| 90681 |
|
243 |
217 |
$0.00 |
| 86328 |
|
1,589 |
983 |
$0.00 |
| 91300 |
|
209 |
74 |
$0.00 |
| 90648 |
|
39 |
30 |
$0.00 |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
12 |
12 |
$0.00 |
| 3015F |
|
41 |
39 |
$0.00 |
| 3046F |
|
18 |
12 |
$0.00 |